Skip to contentB
Bioadaptives, Inc.
B
BDPTBioadaptives, Inc. Q1 2020 · 10-Q
Revenue$4.66K$4.66K+203.9% vs Q1 2019 Net Income-$237.92K-$237.92KN/M vs Q1 2019 EPS Diluted-$0.01-$0.01— vs Q1 2019 Gross Profit$3,293+176.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioadaptives, Inc. · CIK 1575142 · Engraved from SEC EDGAR
Margins · derivedGross margin70.7%−7.1 pt vs Q1 2019
Net margin-5111.1%
ended Mar 31, 2020 · filed Jun 10, 2020 · 71 d after period end